Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9609 posts found.

UCB appoints Peter Theil as head of non-clinical development

November 28, 2011 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing UCB

Peter Theil has joined UCB as its new vice president and head of non-clinical development for the firm’s new medicines …
Appointment

The changing of the guard – Q3 round up

November 25, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Lipitor, Q3, Ranbaxy

 PfizerOf all the patent cliffs in pharma, Lipitor’s expiry represents the biggest. Pfizer is now staring over the precipice, with …
Feature
NICE hq pic

NICE okays Eliquis for blood clots after surgery

November 25, 2011 Research and Development, Sales and Marketing BMS, Eliquis, NICE, Pfizer

NICE is recommending Pfizer and Bristol-Myers Squibb’s Eliquis for blood clots after surgery. Specifically, NICE has said that Eliquis (apixaban) …
News
screen_shot_2011-11-24_at_13

RSA announces raft of new appointments

November 24, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

RSA, the global life sciences executive search and interim management firm, has announced a series of new appointments. RSA Switzerland …
Appointment

Adaptive Trial Design

November 24, 2011 Research and Development

Despite the burgeoning interest in Adaptive Trial Design (ATD), an extremely powerful tool when used effectively in the appropriate circumstances, …
Feature
White paper
glyn_edwards

Glyn Edwards appointed interim chief executive of the BioIndustry Association

November 24, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BIA, Glyn Edwards

The BioIndustry Association (BIA) has appointed Glyn Edwards as its interim chief executive effective immediately. Edwards was previously chief executive …
Appointment
screen_shot_2011-11-24_at_09

Professor Sir Michael Rawlins reappointed as NICE chairman

November 24, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NICE, Rawlins

The National Institute for Health and Clinical Excellence (NICE) has reappointed Professor Sir Michael Rawlins as NICE chairman for a …
Appointment

Big pharma counts cost of R&D decline

November 23, 2011 Research and Development Deloitte, GSK, IIR, R&D productivity

Leading pharma firms are getting around 30% less on their investments in research and development compared to last year, according …
News

Pharmalink elects Anders Wiklund as its new board chairman

November 23, 2011 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Pharmalink

Swedish speciality firm Pharmalink AB has elected Anders Wiklund to serve as its new chairman of the board. In addition …
Appointment

Pancreatic cancer sees lowest improvement in cancer survival

November 23, 2011 Medical Communications, Research and Development Cancer, Macmillan, pancreatic

A new cancer survival study shows that pancreatic cancer continues to have one of the worst mortality rates.  The study …
News

Changes to the EMA’s registration process for SMEs

November 22, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates

The European Medicines Agency (EMA) has recently made changes to its process for the registration of micro, small or medium-sized …
News
Press release

AstraZeneca appoints two new senior leaders in its Americas division

November 22, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca

AstraZeneca has appointed Rich Fante as regional vice president of the Americas, and Marion McCourt as chief operating officer of …
Appointment

Thomas Thorp promoted to senior director of corporate affairs at Lilly UK

November 22, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing lilly

Thomas Thorp has been promoted to senior director of corporate affairs at Lilly UK. Thorp will now lead all of …
Appointment
Eylea picture

Lucentis rival gains US approval

November 22, 2011 Research and Development, Sales and Marketing Bayer, Eylea, Lucentis, Novartis, Regeneron, Roche

A rival to Roche and Novartis’ drug Lucentis has received FDA approval for a common form of eye disease. Eylea …
News

Gilead aims for hep C lead with Pharmasset acquisition

November 22, 2011 Research and Development Gilead, HCV, Pharmasset, Victrelis, hepatitis C

Gilead Sciences is to buy Pharmasset for $11 billion in a bid to become a leader in hepatitis C treatment.The …
News
The Gateway to Local Adoption Series

Latest content

Sandoz launches allergy relief nasal spray in Germany and Switzerland

April 9, 2026

Japan approve Daiichi Sankyo’s Enhertu as a second-line treatment for gastric cancer

April 9, 2026

Trelleborg to take part in Medtec Japan 2026

April 8, 2026

Kainova Therapeutics expands phase I/II trial of antibody drug

April 7, 2026

Eisai starts enrolment for phase 2 narcolepsy study evaluating E2086

April 7, 2026